AI assistant
Sending…
ORTHOPEDIATRICS CORP — Director's Dealing 2017
Oct 11, 2017
32906_dirs_2017-10-11_6ab3ded4-b920-43bd-a12d-2155c48a8996.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2017-10-11
Reporting Person: Throdahl Mark C (Director, President and CEO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 180642 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $30.97 | 2020-09-01 | Common Stock (670) | Direct | |
| Stock Option (Right to Buy) | $30.97 | 2021-08-02 | Common Stock (402) | Direct | |
| Stock Option (Right to Buy) | $30.97 | 2022-08-23 | Common Stock (402) | Direct | |
| Stock Option (Right to Buy) | $30.97 | 2023-09-10 | Common Stock (402) | Direct | |
| Series B Convertible Preferred Stock | $13.09 | Common Stock (7640) | Direct |
Footnotes
F1: The stock option is fully vested and immediately exercisable.
F2: The Series B Convertible Preferred Stock is convertible at any time at the holder's election into shares of Common Stock at the then-existing conversion price, and has no expiration date.
More from ORTHOPEDIATRICS CORP
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 20
Capital/Financing Update
2026
Apr 1
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Investor Presentation
2026
Feb 26